← FDA Drug Approvals (Drugs@FDA)

AVOPEF

NDA · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2026-02-13

Drug application

FDA Application #

NDA220200

Application type

New Drug Application

Brand name

AVOPEF

Generic name

ETOPOSIDE

Active ingredients

ETOPOSIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AVYXA HOLDINGS

Manufacturer

Avyxa Pharma, LLC

First approval

2026-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown